Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Consumer Groups Have A ‘Radical Transparency’ List For US FDA’s PDUFA VIII
Jul 24 2025
•
By
Sarah Karlin-Smith
FDA is being pushed to live up to their word on transparency when it comes to their user fee funding agreements with industry.
(Shutterstock)
Explore how consumer health is evolving. On the go.
David Ridley hosts in-depth conversations with industry leaders.
More from Policy & Regulation
More from Health